Ex Parte WeberDownload PDFPatent Trial and Appeal BoardMay 31, 201814538415 (P.T.A.B. May. 31, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE FIRST NAMED INVENTOR 14/538,415 11/11/2014 Roland Anton Weber 45473 7590 06/01/2018 EGL/Research Triangle Park P.O. BOX 110285 RESEARCH TRIANGLE PARK, NC 27709 UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 14598-35 9400 EXAMINER FUQUA, SHAWNTINA T ART UNIT PAPER NUMBER 3742 MAIL DATE DELIVERY MODE 06/01/2018 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ROLAND ANTON WEBER Appeal2017-008746 Application 14/538,415 Technology Center 3700 Before JOHN C. KERINS, EDWARD A. BROWN, and LYNNE H. BROWNE, Administrative Patent Judges. KERINS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Roland Anton Weber (Appellant) appeals under 35 U.S.C. § 134(a) from the Examiner's final decision rejecting claims 1-10 and 12. We have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM-IN-PART. CLAIMED SUBJECT MATTER Appellant's invention relates to an apparatus for cutting planar substrates charged with pharmaceutically active agents. Spec. para. 2. Appeal2017-008746 Application 14/538,415 Claims 1 and 12 are independent. Claim 1 is illustrative of the claimed invention and reads as follows: 1. An apparatus for cutting continuous planar substrates charged with pharmaceutically active agents, wherein the apparatus comprises: i) a feeding mechanism, wherein the feeding mechanism comprises a first and a second pair of rollers; ii) a cutting zone, wherein the cutting zone is between the pairs of rollers; and iii) one or more cutting lasers capable of making segment- like cuts in the continuous planar substrate within the cutting zone, wherein the continuous planar substrate is charged with one or more pharmaceutically active agents. THE REJECTIONS The Examiner has rejected: (i) claims 1, 2, 5-10, and 12 under 35 U.S.C. § I03(a) as being unpatentable over Stelzl (US 2008/0263841 Al, published Oct. 30, 2008); and (ii) claims 3 and 4 under 35 U.S.C. § I03(a) as being unpatentable over Stelzl and Nagashima (US 4,642,659, issued Feb. 10, 1987). ANALYSIS Claims 1, 2, 5-10, and 12--0bviousness--Stelzl Appellant presents the same arguments for independent claims 1 and 12. See Br. 5-7. Appellant does not present separate arguments directed to dependent claims 2 and 5-10. Id. We thus regard claims 1, 2, 5-10, and 12 as being argued as a group. We take claim 1 as representative of this group, and claims 2, 5-10, and 12 stand or fall with claim 1. 2 Appeal2017-008746 Application 14/538,415 The Examiner finds that Stelzl discloses an apparatus for cutting planar substrates having all of the claimed limitations, but does not disclose that the substrate being cut is charged with a pharmaceutical agent. Final Act. 2 ( citing Stelzl Figs. 1-2). More particularly, the Examiner points to guide rollers 16, 17, 18, and 19 of Stelzl as meeting the claim limitation calling for a feeding mechanism having a first and a second pair of rollers. Id. The Examiner additionally takes the position that substrates charged with pharmaceutical agents are conventional. Id. The Examiner concludes that it would have been obvious to modify the apparatus of Stelzl to process a substrate charged with pharmaceutical agents as a matter of design choice. Id. at 2-3. Appellant contends that Stelzl does not disclose a feeding mechanism comprising a pair of rollers. Br. 6. Appellant argues that Stelzl discloses that the set of rollers 16, 17, 18, and 19 are guide rollers that are not used for feeding material into the apparatus, and that roll 21 is a feeding mechanism as it is driven by an electric motor. Id. As such, Appellant contends that the feeding mechanism of Stelzl comprises a single roller. Id. This argument is unpersuasive. As the Examiner explains, the rollers 16, 17, 18, and 19 of Stelzl form a part of a feeding mechanism because the rotation of those rollers allows the substrates to be fed through a cutting zone more efficiently. Ans. 3. Further, claim 1 does not require that the recited first and second pair of rollers are driven by a motor(s). Appellant additionally argues that the Examiner erroneously relies on design choice to modify the apparatus of Stelzl. Br. 6. Appellant argues that the Specification discloses cutting complex shapes and sizes from a substrate charged with pharmaceutically active agents as well as well as scoring or 3 Appeal2017-008746 Application 14/538,415 cutting multilayer substrates. Id. at 7 ( citing Spec. para. 6). Appellant further argues that the Examiner fails to provide any reason why the skilled artisan would look to Stelzl for a solution to cutting substrates charged with pharmaceutically active agents, or to replace metal substrates utilized in the apparatus of Stelzl with substrates charged with pharmaceutically active agents, to arrive at the claimed invention. Id. Appellant's contentions do not apprise us of Examiner error. As pointed out by the Examiner, claim 1 does not explicitly require that the apparatus be configured to cut complex shapes and sizes from substrates, or to score or cut multilayer substrates. Ans. 4. The Examiner also points out that Appellant's Specification discloses that substrates with pharmaceutically active agents are conventional. Id. (citing Spec. paras. 3- 7). The Examiner further explains that the apparatus of Stelzl is capable of cutting substrates charged with pharmaceutically active agents. In this regard, Appellant's argument that Stelzl is limited to cutting metal substrates (Br. 7) is undermined by the Stelzl disclosure, which identifies that at least several other types of substrates, including coated paper, may be processed by the cutting apparatus therein. Stelzl, para. 2. Neither Appellant's Specification nor any other evidence of record persuasively establishes any criticality or unexpected results obtained by employing substrates that are charged with pharmaceutically active agents for the claimed cutting apparatus. Accordingly, we sustain the rejection of claims 1, 2, 5-10 and 12 as being unpatentable over Stelzl. 4 Appeal2017-008746 Application 14/538,415 Claims 3 and 4--0bviousness--Stelzl/Nagashima The Examiner relies on Nagashima as disclosing an apparatus that is capable of: applying a braking force to a substrate; applying a displacement torque to a substrate; and rotating rollers in opposite directions from each other. Id. ( citing N agashima co 1. 7, 11. 3 9---64). The Examiner concludes that it would have been obvious to modify the apparatus of Stelzl to include these capabilites, as taught by Nagashima, in order to allow the substrate processed therein to be properly stretched. Id. Appellant contends that no sufficient reasoning is provided by the Examiner for making the proposed modification. Br. 8. Appellant argues that nothing in Stelzl indicates that improper stretching of the substrates is a problem that needs to be addressed. Id. at 9. Appellant's contentions are persuasive. Nagashima discloses tensioning or stretching paper that has already been cut, for printing purposes. See Nagashima Abstract; col. 3, 11. 48-56; col. 7, 11. 39---64. The Examiner fails to establish that the apparatus of Stelzl, which transports a continuous web of material through a cutting zone from a feed roll to a take- up roll driven by an electric motor, does not provide sufficient tensioning or stretching of the web or substrate. As such, the articulated reason to modify the apparatus of Stelzl, namely to allow the substrates to be properly stretched, lacks rational underpinnings. The rejection of claims 3 and 4 is therefore not sustained. DECISION The rejection of claims 1, 2, 5-10, and 12 under 35 U.S.C. § 103(a) as being unpatentable over Stelzl is affirmed. 5 Appeal2017-008746 Application 14/538,415 The rejection of claims 3 and 4 under 35 U.S.C. § 103(a) as being unpatentable over Stelzl and Nagashima is reversed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED-IN-PART 6 Copy with citationCopy as parenthetical citation